Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 4/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14073395 | 0.95 | SRD5A2 (0.50) | SRD5A2PDK2CYP2C8NPC1RAB9A | |
| SCHEMBL1637360 | 0.89 | ALDH1A1 (0.53) | SRD5A2PDK2ALDH1A1LMNARAB9A | |
| SCHEMBL14073419 | 0.82 | SIRT1 (0.54) | SRD5A2PDK2ALDH1A1LMNANPC1 | |
| SCHEMBL10227418 | 0.80 | ALDH1A1 (0.53) | SRD5A2PDK2ALDH1A1LMNARAB9A | |
| SCHEMBL9776264 | 0.80 | SRD5A2 (0.68) | SRD5A2KDM1ACYP1A1CYP1B1ALDH1A1 | |
| SCHEMBL14073390 | 0.79 | PDK2 (0.44) | PDK2ALDH1A1LMNANPC1RAB9A | |
| SCHEMBL14073388 | 0.76 | CNR2 (0.50) | PDK2LMNANPC1 | |
| SCHEMBL28558518 | 0.75 | SRD5A2 (0.61) | SRD5A2CYP1A1CYP1B1ALDH1A1LMNA | |
| SCHEMBL13045515 | 0.74 | PDK2 (0.52) | PDK2 | |
| SCHEMBL20036916 | 0.74 | PDK2 (0.41) | PDK2ALDH1A1LMNANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9461249-B2 | Compounds for organic electronic devices | MERCK PATENT GMBH (DE) | 2016-10-04 | — | — | US | disclosed |
| US-20150031896-A1 | COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031896-A1 | COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES | TYR, TOE1, GPX1 | SRD5A2 1536/4885PDK2 1138/4885KDM1A 876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.